1
|
Puvvada RK, Undela K, Parthasarathi G. Prevalence, Risk Factors, and Cost Burden of Fall-Related Hospital Admissions in india. Sr Care Pharm 2021; 36:343-349. [PMID: 34144724 DOI: 10.4140/tcp.n.2021.343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE: To assess prevalence, risk factors, and cost burden of fall-related hospital admissions among older people in India. Previous studies conducted in India have not focused on the number of fall-related hospital admissions.<br/> DESIGN: A prospective observational study was carried out over 12 months. Socio-demographic, medical and medication details were collected from the patients, medical records, and treating physicians.<br/> SETTING: The study was conducted in internal medicine, orthopedics, and emergency departments of a tertiary care teaching hospital in Mysuru, Southern India.<br/> PARTICIPANTS: Patients 60 years of age or older, of any gender, admitted to hospital were included in this study.<br/> MAIN OUTCOME MEASURE: Prevalence of fall-related hospital admission, fall-related hospital admission associated with medication use, and direct cost incurred due to fall-related hospital admission.<br/> RESULTS: A total of 1,036 patients [Males 53.6%] with a mean (SD) age of 69.3 (8.1) years were included in the study. A total of 188 patients were admitted due to falling with the prevalence of 18.1%. The majority of patients fell due to environmental factors [105 (55.8%)]. Among medication-related falls (20), the majority were associated with the use of antihyperglycemics and antihypertensives. Increasing age, female gender, and multiple comorbidities were identified as risk factors for fall-related hospital admissions.<br/> CONCLUSIONS: Falls are a common reason for hospital admission among older populations. Clinicians need to focus on modifiable risk factors to reduce the prevalence of falls and advise patients and their caregivers about appropriate self-care behaviors.
Collapse
Affiliation(s)
- Rahul Krishna Puvvada
- 1Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India
| | - Krishna Undela
- 2Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research Guwahati. Assam, India
| | | |
Collapse
|
2
|
Correa-Pérez A, Delgado-Silveira E, Martín-Aragón S, Cruz-Jentoft AJ. Fall-risk increasing drugs and recurrent injurious falls association in older patients after hip fracture: a cohort study protocol. Ther Adv Drug Saf 2019; 10:2042098619868640. [PMID: 31632633 PMCID: PMC6767747 DOI: 10.1177/2042098619868640] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2019] [Accepted: 07/18/2019] [Indexed: 12/26/2022] Open
Abstract
Polypharmacy and fall-risk increasing drugs (FRIDS) have been associated with
injurious falls. However, no information is available about the association
between FRIDS and injurious falls after hospital discharge due to hip fracture
in a very old population. We aim to assess the association between the use of
FRIDS at discharge and injurious falls in patients older than 80 years
hospitalized due to a hip fracture. A retrospective cohort study using routinely
collected health data will be conducted at the Orthogeriatric Unit of a teaching
hospital. Patients will be included at hospital discharge (2014), with a 2-year
follow-up. Fall-risk increasing drugs will be recorded at hospital discharge,
and exposure to drugs will be estimated from usage records during the 2-year
follow-up. Injurious falls are defined as falls that lead to any kind of health
care (primary or specialized care, including emergency department visits and
hospital admissions). A sample size of 193 participants was calculated, assuming
that 40% of patients who receive any FRID at discharge, and 20% who do not, will
experience an injurious fall during follow up. This protocol explains the study
methods and the planned analysis. We expect to find a relevant association
between FRIDS at hospital discharge and the incidence of injurious falls in this
very old, high risk population. If confirmed, this would support the need for a
careful pharmacotherapeutic review in patients discharged after a hip fracture.
However, results should be carefully interpreted due to the risk of bias
inherent to the study design.
Collapse
Affiliation(s)
- Andrea Correa-Pérez
- Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Crta. Colmenar Km 9.1, Madrid 28034, Spain
| | - Eva Delgado-Silveira
- Servicio de Farmacia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
| | - Sagrario Martín-Aragón
- Departamento de Farmacología, Facultad de Farmacia, Universidad Complutense, Madrid, Spain
| | | |
Collapse
|
3
|
Correa-Pérez A, Delgado-Silveira E, Martín-Aragón S, Rojo-Sanchís AM, Cruz-Jentoft AJ. Fall-risk increasing drugs and prevalence of polypharmacy in older patients discharged from an Orthogeriatric Unit after a hip fracture. Aging Clin Exp Res 2019; 31:969-975. [PMID: 30276631 DOI: 10.1007/s40520-018-1046-2] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2018] [Accepted: 09/24/2018] [Indexed: 12/30/2022]
Abstract
BACKGROUND Polypharmacy and fall-risk increasing drugs (FRIDS) have been associated with injurious falls. We aimed to estimate the prevalence of polypharmacy and FRIDS in older patients discharged from an Orthogeriatric Unit after a hip fracture surgery. METHODS This study describes the baseline findings of a 2-year retrospective cohort study. We included patients older than 80 years discharged from an Orthogeriatric Unit who were able to walk before surgery. Patient's baseline variables, total number of drugs, and FRIDS at hospital discharge were collected. RESULTS We included 228 patients. The mean number of drugs and FRIDS prescribed at discharge was 11.6 ± 3.0 and 2.9 ± 1.6, respectively. Polypharmacy was prevalent in all patients except in three: 23.3% (5-9 drugs) and 75.9% (≥ 10 drugs). Only 11 patients had no FRIDS and 35.5% were on > 3 FRIDS. The most prevalent FRIDS were: agents acting on the renin-angiotensin system (43.9%) and anxiolytics (39.9%). The number of FRIDS was higher in patients with extreme polypharmacy (3.4 ± 1.5) than in those on 5-9 drugs (1.5 ± 1.0, p < 0.05). Independent people in performing instrumental activities had lower risk of extreme polypharmacy (≥ 10 drugs) or > 3 FRIDS: OR 0.39 (95% CI 0.18-0.83) and OR 0.41 (95% CI 0.20-0.84), respectively. People living in a nursing home had higher risk of > 3 FRIDS: OR 4.03 (95% CI 1.12-14.53). CONCLUSIONS Polypharmacy and fall-risk increasing drugs are prevalent in patients discharged from orthogeriatric care after surgery for a hip fracture. Interventions on drug use at hospital discharge could have a potential impact on falls in this high-risk population.
Collapse
Affiliation(s)
- Andrea Correa-Pérez
- Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Crta. Colmenar Km 9.1, 28034, Madrid, Spain.
| | - Eva Delgado-Silveira
- Servicio de Farmacia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
| | - Sagrario Martín-Aragón
- Departamento de Farmacología, Facultad de Farmacia, Universidad Complutense, Madrid, Spain
| | | | - Alfonso J Cruz-Jentoft
- Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Crta. Colmenar Km 9.1, 28034, Madrid, Spain
| |
Collapse
|
4
|
Li Y, Zhang Q, Yang X, Zheng L, Yang J, Zhao H, Yang D. Research of falls risk of taking central nervous system drugs in oncology inpatients. Curr Probl Cancer 2018; 42:261-267. [PMID: 29580676 DOI: 10.1016/j.currproblcancer.2018.01.008] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2016] [Revised: 09/10/2017] [Accepted: 01/07/2018] [Indexed: 11/24/2022]
Abstract
This study aimed to analyze the medication use and related falls risk of central nervous system(CNS) drugs in oncology inpatients, explore the association between CNS drugs and falls. In this study, we enrolled inpatients, hospitalized in the oncology department of the Teaching Hospital of Chengdu University of Traditional Chinese Medicine, from March 2013 to October 2015. All inpatients were divided into two groups: taking-CNS drugs group (treatment group) and non CNS drugs group (control group). The falls risk between two groups were being compared and analyzed. Results showed that a total of 768 inpatients were enrolled in this study; 401 of them were males and 367 were females; the average age was 47.9±5.8 year-old. Of them, 129 were taking CNS drugs, while 639 were not. In the treatment group, the number of fall patients was 39, at an incidence rate of 30.23%; of the 39 fall patients, 3 suffered fractures, and 1 suffered an intracranialhemorrhage; while in the control group, the incidence of falls totaled at 45, at an incidence rate of 7.04%; 4 of the patients suffered fractures. The difference of incidence rate between two groups had statistical significance (P< 0.01). The incidence rate of falls in the treatment group was 4.29 times that in the control group. By the further analysis of CNS drugs, results implied that hypnotics, sedatives, selective serotonin reuptake inhibitors (no patient taking tricyclic antidepressants in this study), opioids, antiepileptics and antipsychotics had relationship with falls (OR>1). Our finding indicates that oncology inpatients have a higher risk of falls resulting from taking CNS drugs. Therefore, it is necessary to build up a systemic mechanism of nursing safety management on preventing falls of oncology inpatients, to improve nursing quality, and reduce the risk of falls.
Collapse
Affiliation(s)
- Yadi Li
- Neurology Department, the Teaching Hospital of Chengdu University of TCM, Chengdu, China
| | - Qing Zhang
- Neurology Department, the Teaching Hospital of Chengdu University of TCM, Chengdu, China
| | - Xuhong Yang
- Neurology Department, the Teaching Hospital of Chengdu University of TCM, Chengdu, China.
| | - Lijun Zheng
- Oncology Department, the Teaching Hospital of Chengdu University of TCM, Chengdu, China
| | - Jun Yang
- Oncology Department, the Teaching Hospital of Chengdu University of TCM, Chengdu, China
| | - Huan Zhao
- Neurology Department, the Teaching Hospital of Chengdu University of TCM, Chengdu, China
| | - Dongdong Yang
- Neurology Department, the Teaching Hospital of Chengdu University of TCM, Chengdu, China
| |
Collapse
|
5
|
Homer ML, Palmer NP, Fox KP, Armstrong J, Mandl KD. Predicting Falls in People Aged 65 Years and Older from Insurance Claims. Am J Med 2017; 130:744.e17-744.e23. [PMID: 28111165 PMCID: PMC5441951 DOI: 10.1016/j.amjmed.2017.01.003] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/04/2016] [Revised: 12/30/2016] [Accepted: 01/02/2017] [Indexed: 11/25/2022]
Abstract
BACKGROUND Accidental falls among people aged 65 years and older caused approximately 2,700,000 injuries, 27,000 deaths, and cost more than 34 billion dollars in the US annually in recent years. Here, we derive and validate a predictive model for falls based on a retrospective cohort of those 65 years and older. METHODS Insurance claims from a 1-year observational period were used to predict a fall-related claim in the following 2 years. The predictive model takes into account a person's age, sex, prescriptions, and diagnoses. Through random assignment, half of the people had their claims used to derive the model, while the remaining people had their claims used to validate the model. RESULTS Of 120,881 individuals with Aetna health insurance coverage, 12,431 (10.3%) members fell. During validation, people were risk stratified across 20 levels, where those in the highest risk stratum had 10.5 times the risk as those in the lowest stratum (33.1% vs 3.1%). CONCLUSIONS Using only insurance claims, individuals in this large cohort at high risk of falls could be readily identified up to 2 years in advance. Although external validation is needed, the findings support the use of the model to better target interventions.
Collapse
Affiliation(s)
- Mark L Homer
- Computational Health Informatics Program, Boston Children's Hospital, Boston, Mass; Department of Biomedical Informatics, Harvard Medical School, Boston, Mass
| | - Nathan P Palmer
- Computational Health Informatics Program, Boston Children's Hospital, Boston, Mass; Department of Biomedical Informatics, Harvard Medical School, Boston, Mass
| | | | | | - Kenneth D Mandl
- Computational Health Informatics Program, Boston Children's Hospital, Boston, Mass; Department of Biomedical Informatics, Harvard Medical School, Boston, Mass.
| |
Collapse
|
6
|
Bonafede M, Shi N, Barron R, Li X, Crittenden D, Chandler D. Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data. Arch Osteoporos 2016; 11:26. [PMID: 27475642 PMCID: PMC4967418 DOI: 10.1007/s11657-016-0280-5] [Citation(s) in RCA: 75] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2016] [Accepted: 07/07/2016] [Indexed: 02/03/2023]
Abstract
UNLABELLED Patient characteristics contributing to imminent risk for fracture, defined as risk of near-term fracture within the next 12 to 24 months, have not been well defined. In patients without recent fracture, we identified factors predicting imminent risk for vertebral/nonvertebral fracture, including falls, age, comorbidities, and other potential fall risk factors. PURPOSE Several factors contribute to long-term fracture risk in patients with osteoporosis, including age, bone mineral density, and fracture history. Some patients may be at imminent risk for fracture, defined here as a risk of near-term fracture within 12-24 months. Many patient characteristics contributing to imminent risk for fracture have not been well defined. This case-control study used US commercial and Medicare supplemental insured data for women and men without recent fracture to identify factors associated with imminent risk for fracture. METHODS Patients included were aged ≥50 with osteoporosis, had a vertebral or nonvertebral fracture claim (index date; fracture group) or no fracture claim (control group) from January 1, 2006, to September 30, 2012, continuously enrolled and without fracture in the 24 months before index. Potential risk factors during the period before fracture were assessed. RESULTS Using data from 12 months before fracture, factors significantly associated with imminent risk for fracture were previous falls, older age, poorer health status, specific comorbidities (psychosis, Alzheimer's disease, central nervous system disease), and other fall risk factors (wheelchair use, psychoactive medication use, mobility impairment). Similar findings were observed with data from 24 months before fracture. CONCLUSIONS In patients with osteoporosis and no recent fracture, falls, older age, poorer health status, comorbidities, and other potential fall risk factors were predictive of imminent risk for fracture. Identification of factors associated with imminent risk for vertebral/nonvertebral fracture may help identify and risk stratify those patients most in need of immediate and appropriate treatment to decrease fracture risk.
Collapse
Affiliation(s)
| | - N. Shi
- Truven Health Analytics, Cambridge, MA USA
| | - R. Barron
- Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA USA
| | - X. Li
- Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA USA
| | | | - D. Chandler
- Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA USA
| |
Collapse
|